Showing 1–16 of 28 results
Sclavo %PT / Direct INR kit can be used for the following purposes: Establish an INR Reference Curve for the direct INR determination of a patient sample, establish a specific ISI and MNPT values for the system, reagent and instrument, used by the laboratory. establish a %PT Calibration Curve. The device can be used both with manual or automated methods
Sclavo Antithrombin (Factor Xa) LRT is a chromogenic assay for the quantitative determination of antithrombin (AT) activity in human plasma citrate using an anti-Xa. The determination of antithrombin levels is used as an aid in the diagnosis and monitoring of congenital or acquired diseases. Acquired antithrombin deficiency may result from reduced synthesis, increased protein consumption, or as a consequence of protein loss in conditions such as DIC (disseminated intravascular coagulation), sepsis, acute hemolytic transfusion reaction, increased protein loss in nephrotic syndrome, thrombotic microangiopathies, malignancies, acute thrombotic episodes, and asparaginase therapy. The device can be used with manual or automated methods
In vitro medical diagnostic device used for the determination of activated partial thromboplastin times, with optimum sensitivity to factor deficiencies, heparin, lupus-like inhibitors, and related coagulation procedures using phospholipid extract and a near-colloidal particle activator. The activated partial thromboplastin time (aPTT) is used to detect disorders in the intrinsic coagulation system, which involves coagulation factors VIII, IX, XI, XII, prekallikrein, and high molecular weight kininogen. The aPTT-S is also used in assays which quantitate these factors and in monitoring heparin therapy. The device can be used with manual or automated methods.
In vitro medical diagnostic device used for the determination of activated partial thromboplastin times, with optimum sensitivity to factor deficiencies, heparin, lupus-like inhibitors, and related coagulation procedures using phospholipid extract and a near-colloidal particle activator. The activated partial thromboplastin time (aPTT) is used to detect disorders in the intrinsic coagulation system, which involves coagulation factors VIII, IX, XI, XII, prekallikrein, and high molecular weight kininogen. The aPTT-S is also used in assays which quantitate these factors and in monitoring heparin therapy. The device can be used with manual or automated methods.
Human plasma to be used for the calibration of quantitative coagulation diagnostic methods. The Calibrator can be used manually through the use of spectrophotometer or photometer or with all automatic analyzers that can meet the operating conditions specified for the single parameters.
Sclavo Auto D-Dimer kit is an immunoturbidimetric assay used for the quantitative determination of the fibrin degradation products that contain D-Dimer in human plasma. The device can be used both with manual or automated methods. CONTAINS CALIBRATION PLASMA
The Sclavo Fibrinogen Kit is intended for the quantitative determination of Fibrinogen in human citrated plasma. Levels of Fibrinogen can increase as a result of inflammation, pregnancy or oral contraceptive use. Decreased levels can be
found in certain states such as liver disease and DIC. Congenital deficiencies include afibrinogenaemia (no detectable Fibrinogen), hypofibrinogenaemia (<1 mg/ml) and dysfibrinogenaemia (abnormal Fibrinogen molecule). The device can be used with manual or automated methods.
The Sclavo Fibrinogen Kit is intended for the quantitative determination of Fibrinogen in human citrated plasma. Levels of Fibrinogen can increase as a result of inflammation, pregnancy or oral contraceptive use. Decreased levels can be found in certain states such as liver disease and DIC. Congenital deficiencies include afibrinogenaemia (no detectable Fibrinogen), hypofibrinogenaemia (<1 mg/ml) and dysfibrinogenaemia (abnormal Fibrinogen molecule). The device can be used with manual or automated methods.
The Sclavo D-Dimer high Control Kit contains plasmas with high levels of D-Dimer. This plasma is used as Quality Control reagent to test Accuracy and precision of the Sclavo latex-enhanced immunoassay methods for D-Dimer and should be tested before patient samples to ensure the satisfactory performance of the assay system.
Buffer Solution used to dilute the plasma, the controls and the calibrator, necessary for the
determination of haemostasis’s parameters.
The Sclavo D-Dimer high Control Kit contains plasmas with low levels of D-Dimer. This plasma is used as Quality Control reagent to test Accuracy and precision of the Sclavo latex-enhanced immunoassay methods for D-Dimer and should be tested before patient samples to ensure the satisfactory performance of the assay system.
Sclavo Normal Control Plasma Kit is a normal citrated human plasma, used as a quality control reagent to test Accuracy and precision of quantitative coagulation factors assays. The Control plasma can be used manually through the use of spectrophotometer or photometer or with all automatic analyzers that can meet the operating conditions specified for the single parameters.
Sclavo Abnormal Control Plasma Kit is a pathologic citrated human plasma, used as a quality control reagent to test Accuracy and precision of quantitative coagulation factors assays. The Control plasma can be used manually through the use of spectrophotometer or photometer or with all automatic analyzers that can meet the operating conditions specified for the single parameters.
The Sclavo Chromogenic Protein C Kit is intended for the quantitative determination of protein C in human plasma using a chromogenic assay method. Protein C is a vitamin K dependent protein which plays an important role in the regulation of anticoagulant mechanisms. Both hereditary and acquired Protein C deficiencies have been shown to be a risk factor for development of venous thrombosis. The device can be used both with manual or automated methods.
Sclavo Protein S Kit is an in vitro clotting assay for the quantitative determination of Protein S (PS) in human citrated plasma, with a manual or automated method. Congenital or acquired Protein S deficiencies are a risk factor for venous thrombosis.
